ND Experts on the Opioid Epidemic
The University of Notre Dame hosted the , bringing together more than 100 leaders from across the country, including attorneys general, federal and state officials, foundation leaders and top experts in addiction and public health. This landmark event was focused on developing strategies to effectively distribute nearly $50 billion in opioid settlement funds.
Led by , the summit explored how evidence-based practices can inform decisions and ensure that the National Opioids Settlement best helps those victims it is meant to serve.
View recorded sessions from the summit:
Explore how Notre Dame experts in artificial intelligence, data science, economics and poverty are combating the opioid crisis below.
Notre Dame develops user-friendly platform to access opioid database
To understand the pervasiveness of the opioid epidemic, researchers have developed a user-friendly public database that enables access to more than 10 years of national controlled substance transaction information. The platform makes querying easier and faster, providing transactional data on 14 different opioids.
Taking her science to the streets
Notre Dame chemist Marya Lieberman decided to let the local community鈥檚 needs drive her scientific process and found herself in the fight against fentanyl. Lieberman saw that a quick, low-cost test for fentanyl and other drugs was the answer鈥攐ne that could have an immediate impact, preventing overdoses and giving people second chances they otherwise would not have.
Opioid epidemic reaches beyond health impacts to influence politics
Vicky Barone researched the opioid epidemic and traced the long-term consequences of overdose deaths on the political landscape, finding increased support for conservative beliefs and Republican candidates.
Computer Science Professor Fanny Ye is advancing artificial intelligence to dismantle the complex networks that create and traffic deadly opioids.
Economists conclude opioid crisis responsible for millions of children living apart from parents
A study by Bill Evans and Kasey Buckles was among the first to analyze the impact of the opioid epidemic on the children of drug users.
Study links rising heroin deaths to 2010 OxyContin reformulation
In a working paper, researchers at Notre Dame and Boston University reviewed efforts by Purdue Pharma in 2010 to make OxyContin less prone to abuse. Instead, they found that while prescription opioid consumption stopped rising in August 2010, heroin overdose deaths began climbing the following month.
